{ "api_version": "1", "request": { "url": "https://clinicaltrialsfind.com/api/v1/search.json?city=Tucson&page=68&state=Arizona", "query": { "state": "Arizona", "city": "Tucson", "page": 68 }, "page_size": 10 }, "pagination": { "page": 68, "page_size": 10, "total_count": 5404, "total_pages": 541, "next_page_url": "https://clinicaltrialsfind.com/api/v1/search.json?city=Tucson&page=69&state=Arizona&page_size=10", "previous_page_url": "https://clinicaltrialsfind.com/api/v1/search.json?city=Tucson&page=67&state=Arizona&page_size=10" }, "source": "remote", "last_synced_at": "2026-11-15T07:25:18.797Z", "attribution": "Data derived from public ClinicalTrials.gov records. The official record at https://clinicaltrials.gov/ remains the source of truth for current availability, contacts, and full study details.", "notes": [ "This endpoint exposes only public summary fields — no participant contact emails, phone numbers, or scraped investigator contact details.", "For contact information and full protocol detail, follow each trial's `official_url` to the ClinicalTrials.gov record.", "This API is a navigational aid. It does not provide medical advice, eligibility determinations, or compensation guarantees." ], "trials": [ { "nct_id": "NCT04892446", "title": "Study of Magrolimab Combinations in Patients With Relapsed/Refractory Multiple Myeloma", "overall_status": "TERMINATED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Multiple Myeloma" ], "interventions": [ { "name": "Magrolimab", "type": "DRUG" }, { "name": "Daratumumab", "type": "DRUG" }, { "name": "Pomalidomide", "type": "DRUG" }, { "name": "Dexamethasone", "type": "DRUG" }, { "name": "Bortezomib", "type": "DRUG" }, { "name": "Carfilzomib", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Gilead Sciences", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 36, "start_date": "2021-11-09", "completion_date": "2024-04-25", "has_results": true, "last_update_posted_date": "2025-05-02", "last_synced_at": "2026-11-15T07:25:18.797Z", "location_count": 16, "location_summary": "Tucson, Arizona • La Jolla, California • Palo Alto, California + 13 more", "locations": [ { "city": "Tucson", "state": "Arizona" }, { "city": "La Jolla", "state": "California" }, { "city": "Palo Alto", "state": "California" }, { "city": "Detroit", "state": "Michigan" }, { "city": "Buffalo", "state": "New York" } ], "official_url": "https://clinicaltrials.gov/study/NCT04892446" }, { "nct_id": "NCT00003896", "title": "S9912 Combination Chemo in Stage III Ovarian Cancer,", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Fallopian Tube Cancer", "Ovarian Cancer", "Peritoneal Cavity Cancer" ], "interventions": [ { "name": "cisplatin", "type": "DRUG" }, { "name": "liposomal doxorubicin", "type": "DRUG" }, { "name": "paclitaxel", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "SWOG Cancer Research Network", "sponsor_class": "NETWORK", "healthy_volunteers": false, "eligibility": { "minimum_age": null, "maximum_age": null, "sex": "FEMALE", "summary": "Female only" }, "enrollment_count": 68, "start_date": "1999-09", "completion_date": "2008-02", "has_results": true, "last_update_posted_date": "2013-01-04", "last_synced_at": "2026-11-15T07:25:18.797Z", "location_count": 104, "location_summary": "Tucson, Arizona • Davis, California • Duarte, California + 66 more", "locations": [ { "city": "Tucson", "state": "Arizona" }, { "city": "Davis", "state": "California" }, { "city": "Duarte", "state": "California" }, { "city": "Hayward", "state": "California" }, { "city": "Livermore", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT00003896" }, { "nct_id": "NCT01953588", "title": "Fulvestrant and/or Anastrozole in Treating Postmenopausal Patients With Stage II-III Breast Cancer Undergoing Surgery", "overall_status": "ACTIVE_NOT_RECRUITING", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Estrogen Receptor-positive Breast Cancer", "HER2-negative Breast Cancer", "Invasive Ductal Breast Carcinoma", "Invasive Lobular Breast Carcinoma", "Recurrent Breast Cancer", "Stage II Breast Cancer", "Stage IIIA Breast Cancer", "Stage IIIB Breast Cancer", "Stage IIIC Breast Cancer" ], "interventions": [ { "name": "fulvestrant", "type": "DRUG" }, { "name": "anastrozole", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Alliance for Clinical Trials in Oncology", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "FEMALE", "summary": "18 Years and older · Female only" }, "enrollment_count": 1473, "start_date": "2014-02-27", "completion_date": "2027-04-01", "has_results": false, "last_update_posted_date": "2026-06-05", "last_synced_at": "2026-11-15T07:25:18.797Z", "location_count": 856, "location_summary": "Birmingham, Alabama • Mobile, Alabama • Anchorage, Alaska + 524 more", "locations": [ { "city": "Birmingham", "state": "Alabama" }, { "city": "Mobile", "state": "Alabama" }, { "city": "Anchorage", "state": "Alaska" }, { "city": "Anchorage", "state": "Alaska" }, { "city": "Anchorage", "state": "Alaska" } ], "official_url": "https://clinicaltrials.gov/study/NCT01953588" }, { "nct_id": "NCT02963766", "title": "A Study of Dulaglutide (LY2189265) in Children and Adolescents With Type 2 Diabetes", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Type 2 Diabetes" ], "interventions": [ { "name": "Dulaglutide", "type": "DRUG" }, { "name": "Placebo", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Eli Lilly and Company", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "10 Years", "maximum_age": "17 Years", "sex": "ALL", "summary": "10 Years to 17 Years" }, "enrollment_count": 154, "start_date": "2016-12-29", "completion_date": "2022-01-12", "has_results": true, "last_update_posted_date": "2022-07-01", "last_synced_at": "2026-11-15T07:25:18.797Z", "location_count": 23, "location_summary": "Birmingham, Alabama • Tucson, Arizona • Anaheim, California + 20 more", "locations": [ { "city": "Birmingham", "state": "Alabama" }, { "city": "Tucson", "state": "Arizona" }, { "city": "Anaheim", "state": "California" }, { "city": "Los Angeles", "state": "California" }, { "city": "Orange", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT02963766" }, { "nct_id": "NCT00335556", "title": "Combination Chemotherapy, Radiation Therapy, and/or Surgery in Treating Patients With High-Risk Kidney Tumors", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Childhood Renal Cell Carcinoma", "Clear Cell Renal Cell Carcinoma", "Clear Cell Sarcoma of the Kidney", "Papillary Renal Cell Carcinoma", "Rhabdoid Tumor of the Kidney", "Stage I Renal Cell Cancer", "Stage I Renal Wilms Tumor", "Stage II Renal Cell Cancer", "Stage II Renal Wilms Tumor", "Stage III Renal Cell Cancer", "Stage III Renal Wilms Tumor", "Stage IV Renal Cell Cancer", "Stage IV Renal Wilms Tumor" ], "interventions": [ { "name": "Doxorubicin Hydrochloride", "type": "DRUG" }, { "name": "Irinotecan Hydrochloride", "type": "DRUG" }, { "name": "Conventional Surgery", "type": "PROCEDURE" }, { "name": "Cyclophosphamide", "type": "DRUG" }, { "name": "Etoposide", "type": "DRUG" }, { "name": "Carboplatin", "type": "DRUG" }, { "name": "Dactinomycin", "type": "BIOLOGICAL" }, { "name": "Vincristine Sulfate", "type": "DRUG" }, { "name": "Radiation Therapy", "type": "RADIATION" }, { "name": "Laboratory Biomarker Analysis", "type": "OTHER" } ], "intervention_types": [ "DRUG", "PROCEDURE", "BIOLOGICAL", "RADIATION", "OTHER" ], "sponsor": "Children's Oncology Group", "sponsor_class": "NETWORK", "healthy_volunteers": false, "eligibility": { "minimum_age": null, "maximum_age": "29 Years", "sex": "ALL", "summary": "Up to 29 Years" }, "enrollment_count": 291, "start_date": "2006-06", "completion_date": null, "has_results": true, "last_update_posted_date": "2017-07-21", "last_synced_at": "2026-11-15T07:25:18.797Z", "location_count": 161, "location_summary": "Birmingham, Alabama • Mobile, Alabama • Phoenix, Arizona + 127 more", "locations": [ { "city": "Birmingham", "state": "Alabama" }, { "city": "Birmingham", "state": "Alabama" }, { "city": "Mobile", "state": "Alabama" }, { "city": "Phoenix", "state": "Arizona" }, { "city": "Tucson", "state": "Arizona" } ], "official_url": "https://clinicaltrials.gov/study/NCT00335556" }, { "nct_id": "NCT04809376", "title": "Treatment Effects of Subcutaneous Injections of Pentosan Polysulfate Sodium vs Placebo in Participants With Knee OA Pain", "overall_status": "ACTIVE_NOT_RECRUITING", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2", "PHASE3" ], "conditions": [ "Osteoarthritis, Knee" ], "interventions": [ { "name": "Pentosan Polysulfate Sodium twice weekly", "type": "DRUG" }, { "name": "Placebo (Sodium Chloride Injection, 0.9%)", "type": "DRUG" }, { "name": "Pentosan Polysulfate Sodium Fixed Dose", "type": "DRUG" }, { "name": "Pentosan Polysulfate Sodium once weekly", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Paradigm Biopharmaceuticals USA (INC)", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 602, "start_date": "2021-10-19", "completion_date": "2025-01-06", "has_results": false, "last_update_posted_date": "2024-04-08", "last_synced_at": "2026-11-15T07:25:18.797Z", "location_count": 29, "location_summary": "Tempe, Arizona • Tucson, Arizona • Cerritos, California + 20 more", "locations": [ { "city": "Tempe", "state": "Arizona" }, { "city": "Tempe", "state": "Arizona" }, { "city": "Tucson", "state": "Arizona" }, { "city": "Cerritos", "state": "California" }, { "city": "La Mesa", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT04809376" }, { "nct_id": "NCT02047097", "title": "Dimethyl Fumarate (DMF) Observational Study", "overall_status": "COMPLETED", "study_type": "OBSERVATIONAL", "phases": [], "conditions": [ "Multiple Sclerosis" ], "interventions": [ { "name": "dimethyl fumarate", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Biogen", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 5487, "start_date": "2013-11-19", "completion_date": "2022-10-31", "has_results": false, "last_update_posted_date": "2023-05-24", "last_synced_at": "2026-11-15T07:25:18.797Z", "location_count": 168, "location_summary": "Birmingham, Alabama • Huntsville, Alabama • Gilbert, Arizona + 140 more", "locations": [ { "city": "Birmingham", "state": "Alabama" }, { "city": "Huntsville", "state": "Alabama" }, { "city": "Gilbert", "state": "Arizona" }, { "city": "Phoenix", "state": "Arizona" }, { "city": "Phoenix", "state": "Arizona" } ], "official_url": "https://clinicaltrials.gov/study/NCT02047097" }, { "nct_id": "NCT00044382", "title": "Study of the Safety and Efficacy of CC-5013 Treatment For Patients With Myelodysplastic Syndrome", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Myelodysplastic Syndrome" ], "interventions": [ { "name": "CC-5013", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Celgene", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 25, "start_date": "2002-02-01", "completion_date": "2007-01-30", "has_results": false, "last_update_posted_date": "2019-11-08", "last_synced_at": "2026-11-15T07:25:18.797Z", "location_count": 1, "location_summary": "Tucson, Arizona", "locations": [ { "city": "Tucson", "state": "Arizona" } ], "official_url": "https://clinicaltrials.gov/study/NCT00044382" }, { "nct_id": "NCT01077024", "title": "Smoking-Cessation and Stimulant Treatment (S-CAST)", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Cocaine Dependence", "Methamphetamine Dependence", "Nicotine Dependence" ], "interventions": [ { "name": "Smoking-cessation treatment", "type": "OTHER" } ], "intervention_types": [ "OTHER" ], "sponsor": "University of Cincinnati", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 538, "start_date": "2010-02", "completion_date": "2012-08", "has_results": true, "last_update_posted_date": "2021-09-29", "last_synced_at": "2026-11-15T07:25:18.797Z", "location_count": 12, "location_summary": "Tucson, Arizona • Rancho Cucamonga, California • Tarzana, California + 9 more", "locations": [ { "city": "Tucson", "state": "Arizona" }, { "city": "Rancho Cucamonga", "state": "California" }, { "city": "Tarzana", "state": "California" }, { "city": "Jacksonville", "state": "Florida" }, { "city": "Cape Girardeau", "state": "Missouri" } ], "official_url": "https://clinicaltrials.gov/study/NCT01077024" }, { "nct_id": "NCT02709746", "title": "Active Reference (Fluoxetine) Fixed-dose Study of Vortioxetine in Paediatric Patients Aged 12 to 17 Years With Major Depressive Disorder (MDD)", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Depressive Disorder, Major" ], "interventions": [ { "name": "Vortioxetine 10 mg/day", "type": "DRUG" }, { "name": "Vortioxetine 20 mg/day", "type": "DRUG" }, { "name": "Fluoxetine 20 mg/day", "type": "DRUG" }, { "name": "Placebo", "type": "OTHER" } ], "intervention_types": [ "DRUG", "OTHER" ], "sponsor": "H. Lundbeck A/S", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "12 Years", "maximum_age": "17 Years", "sex": "ALL", "summary": "12 Years to 17 Years" }, "enrollment_count": 784, "start_date": "2016-05", "completion_date": "2019-07-30", "has_results": true, "last_update_posted_date": "2020-08-19", "last_synced_at": "2026-11-15T07:25:18.797Z", "location_count": 42, "location_summary": "Dothan, Alabama • Tucson, Arizona • Little Rock, Arkansas + 37 more", "locations": [ { "city": "Dothan", "state": "Alabama" }, { "city": "Tucson", "state": "Arizona" }, { "city": "Little Rock", "state": "Arkansas" }, { "city": "Costa Mesa", "state": "California" }, { "city": "Downey", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT02709746" } ] }